Cerises 🇨🇵

🇲🇫 🪆 🩵: AI, science, art,Proust,holism.
Bedridden because of 🦠 #LongCovid : #fibrosis #neuropathy #SFN #MCAS🦠
SARS-COV-2 = persistent vascular virus 🦠

[Cerises 🇨🇵 @Moooonflash]

Antivirals (taken in first hours after infection or symptoms) are the only thing that can prevent #LongCovid . If false or not efficient paths are taken for the cure of Long Covid, we will forever be at risk of several cumulative #LongCovid

[Jon Douglas @atranscendedman]

86,122 matched pairs found long COVID was linked to 4.48 times higher risk of major cardiovascular events and 1.53 times higher mortality after COVID infection.

https://t.co/YUsKRckP85

[Alex @alexandrer81988]

Julien, comment le COVID LONG a bouleversé toute sa vie https://t.co/yYfvGyDZcD via @YouTube

[tern @1goodtern]

This story is just heartbreaking.

"The 36-year-old from Cobham has been happily married to James for almost seven years. However, things took a turn after the couple both developed long Covid in 2022.

Although Karen recovered, James’ condition worsened. By 2023 he was completely bed bound and had also developed very severe Myalgic Encephalomyelitis (ME)."

💔😢

https://t.co/RKVTmXe4IM

[Cerises 🇨🇵 @Moooonflash]

@JackHadfield14 https://t.co/wX4jpYK2qY

[Cerises 🇨🇵 @Moooonflash]

My PEM reappeared in a couple of recent acute Covid reinfections. Disappeared quickly with my antiviral SARS-CoV-2 treatment (aspen bark tincture). From my 6 years experience PEM is the most viral load (VL) related symptom (it also depends on some specific tissues with the VL).

[Cerises 🇨🇵 @Moooonflash]

@Zedzies Yep, unfortunately an antibiotic:( Even in the under dosage, too risky with already destroyed by SARS-CoV-2 GI :(

[Cerises 🇨🇵 @Moooonflash]

Long Covid people should watch MMP9.
Not just a “tissue damage enzyme.” In a 2026 JDS skin study, keratinocyte MMP9 shifted substance P processing toward SP1-9, a fragment that activates mast cells via MRGPRX2/MrgprB2.
Nerve → protease → mast-cell inflammation loop.

[Laura Miers @LauraMiers]

@BirdieBittern We once acknowledged this.

In 2023, we also confirmed SARS-CoV-2 causes immunodeficiency like HIV/AIDS, so not only are we all immunocompromised, Covid & the wide range of pathogens & superbugs we have allowed to run rampant are going to more easily kill us.

[Cerises 🇨🇵 @Moooonflash]

https://t.co/1YAgNNugDG

[Cerises 🇨🇵 @Moooonflash]

https://t.co/ulqO0TaaTB

[Cerises 🇨🇵 @Moooonflash]

My PEM reappeared in a couple of recent acute Covid reinfections. Disappeared quickly with my antiviral SARS-CoV-2 treatment (aspen bark tincture). From my 6 years experience PEM is the most viral load (VL) related symptom (it also depends on some specific tissues with the VL).

[PolyBio @polybioRF]

11:40—Dominique Salmon discussed results of a pilot trial of Maraviroc & Pravastatin in Long COVID patients with gastrointestinal symptoms. There was a rapid & sustained improvement in GI symptoms in most patients. During treatment, there was a reduction in viral RNA & plasma Spike protein in 75% and 58% of patients respectively. A reduction of microclots was observed in 75% of patients.

[Bat Pitt 🦇 @ManniloTrader]

Ewingella americana
A tree frog gut bacteria systemic cancer treatment

Complete response

insane!
also scary because of injecting a 🐸 gut bacteria into your veins, you might immediately think "sepsis".

But it seems to only seek and attack the tumors.

https://t.co/0B3VjBHbQd

[Bat Pitt 🦇 @ManniloTrader]

Maraviroc, Leronlimab. CCR5+

https://t.co/4IOWllvyBc

[Cat (CovidSolidarity) @CovidSolidarit1]

Not going to lie - very concerned about what SarsCov2 is going to do to brains in the long term.

[ApresJ20 - Association Covid Long France @apresj20]

🚨 Participez à une enquête européenne sur le #CovidLong !

Nous avons contribué, en tant qu’association #ApresJ20 à ce questionnaire porté par l’EUPHA et l’OCDE afin de mieux comprendre les enjeux et besoins des patients vivants avec un Covid Long.
👇👇👇

[Daniel Brittain Dugger @dbdugger]

@AlbaDocherty @TheWHN @DavidJoffe64 The research extends to Long Covid, doesn't it?
Case series: Maraviroc and pravastatin as a therapeutic option to treat long COVID/Post-acute sequelae of COVID (PASC)
https://t.co/Qtu30sWMB9

[Cat (CovidSolidarity) @CovidSolidarit1]

Having watched the symposium I can confirm this is correct.

[Robert 😷 Long COVID 6 🇨🇦🇺🇸🏳️‍🌈 @Rob_DeRosa]

Can’t believe I’m only coming across this paper now after today’s symposium.

For 6 years I’ve been saying my long COVID is SARS-CoV-2 persisting in my nasopharynx and upper airway since day one of my infection. Persistent inflammation. Chronic mucus. Immune activation that never switched off. Something that simply never cleared.

Nobody wanted to hear it. So many eye rolls and blank stares. Dismissed on the regular. Well here we are now. These pictures don’t lie.

This Cell Host & Microbe paper using [18F]F-AraG PET imaging found elevated immune activation specifically in the olfactory and nasopharyngeal region in long COVID patients. Exactly. Where. I. Have. Been. Pointing.

This is what serious long COVID researchers and patients have been saying for years: SARS-CoV-2 persists in mucosal tissues (the gut + nasopharynx especially) and that persistence is what is driving our illness. This paper fits that framework precisely.

For the folks like me with chronic mucus issues, smell changes, neurocognitive symptoms, GI issues, and that feeling something “never cleared,” this is finally research that says: “I hear you” & “I see you.”

So again as I’ve said before and I’ll say it again - mark my words - : viral persistence in the upper airway/nasopharynx = long COVID.

🔗 https://t.co/hIq6G0Xz1s

[💜Javichu @javichu73]

You’re all very young, but there was a time when talking about the viral persistence of SARS-CoV-2 was almost considered heresy.

Today, there’s no doubt about it.

#LongCOVID #COVIDPersistente

👇